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List of abbreviations: 
 
ANOVA - analysis of variance 
AUC - area under the curve 
BV - bipolar voltage 
CI - confidence interval 
cMRI - cardiovascular magnetic resonance imaging 
Cx - circumflex artery 
EDV - end-diastolic volume 
EDWT - end-diastolic wall thickness 
ESV - end-systolic volume 
ESWT - end-systolic wall thickness 
EMM - electromechanical mapping 
FWHM - full-width-half-maximum 
Gd(DTPA-BMA) - gadodiamide 
LAD - left anterior descending artery 
LLS - linear local shortening 
LVmassED - left ventricular mass at the end diastole 
MI - myocardial infarction 
ROC - receiver operator characteristics 
SEM - standard error of mean 
SI - signal intensity 
SV - stroke volume 
T% - infarct transmurality 
UV - unipolar voltage 
VF - ventricular fibrillation 
WM - wall motion 
WT - wall thickening 
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1. INTRODUCTION 
 
1.1 Review of the literature  
 
Myocardial infarction (MI) with the loss of myocardium and the consequent 
remodeling and heart failure is still the leading cause of mortality in the 
industrialized countries, despite the trend toward the decreasing 30-day mortality [1, 
2]. Early successful reperfusion therapy results in myocardial salvage within the area 
at risk and decreases the prevalence of left ventricular remodeling and congestive 
heart failure [2]. The degree of infarct expansion and the intensity of remodeling 
depend on the time of revascularization. This phenomenon was first described by 
Reimer et al. in 1977 in canine models where coronary occlusion was applied for 
different time frames, and resulted in an inverse relation between the time to 
reperfusion and the size and transmural extent of the infarct [3]. On the other hand 
reestablishment of blood flow is beneficial outside that time frame, which could 
result in myocardial salvage. This was designated as the time-independent effects of 
an opened infarct related artery by Kim and Braunwald [4]. The late restoration of 
coronary blood flow promotes infarct healing and could prevent the process of 
expansion, aneurysm formation or electrical instability. Percutaneous coronary 
interventions allow achieving reperfusion in acute coronary syndromes; however 
there are still a portion of patients who could not receive any reperfusion therapy 
within the desired time range. It is still of high prognostic importance to evaluate the 
size of the infarct related area and to determine myocardial viability among these 
patients in order to estimate the benefit of planned revascularization procedures.  
 
1.2 Animal models - Importance of interspecies differences and the methods 
for the induction of MI 
 
From the numerous animal models of regional myocardial ischemia, the in 
vivo models are preferred in large animals, since the ethical, practical and financial 
issues associated with the study of human tissue. There are several aspects that need 
to be taken into account at the early designing phase of experiments, since they could 
have significant influence, resulting in misleading interpretations. First of all one 
should pay attention on the interspecies difference of the two most utilized animals in 
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the field of cardiovascular research: dogs and porcine. The dog heart consists of large 
epicardial interarterial collaterals, and the distribution of the vasculature mainly 
shows left dominance [5, 6], which is most infrequently seen in humans. The heart of 
porcine species closely resembles to the human heart, regarding the distribution of 
coronary arteries [7] and the small amount of collaterals [5, 8]. Hearse et al. and 
Verdouw et al. suggested that porcine hearts characterized by small amount of 
collaterals resemble to the early phase of human disease, and dogs with extensive 
collaterals resemble the features of patients with chronic coronary artery disease [9, 
10]. Other important aspect of experimental design is the difference in the surgical 
methods of MI induction e.g. the application of open or closed chest methods. Open 
chest models are usually characterized by increased mortality and complication rates 
[11]. Open chest methods induce increased surgical trauma and inflammation 
moreover infections could occur more often [12]. The scar tissue formation and the 
increased presence of air in the tissue layers also influence the local anatomical 
settings, which could deteriorate cMRI image quality [13]. Pericardial incision also 
could affect intrathoracic pressures and hemodynamics [14], while hypothermia [15] 
and body temperature in the normothermic range [16] significantly affects infarct 
size. The catheter-based minimal invasive interventional cardiology techniques 
allowed the wide application of the closed chest methods for the in vivo evaluation 
of MI and are preferable regarding the better survival rates, time and cost 
consumption [11]. Furthermore the closed chest methods allow longer follow-up 
time after therapeutic interventions, promoting further the better and more critical 
interpretation. Large animal models, e.g. porcine, dog, sheep or baboons enable the 
utilization of catheter-based techniques in contrast to small animals. Consequently, 
as mentioned above large animals, especially the porcine heart highly resembles the 
features of humans. Finally as it was summarized by Hearse and colleagues, large 
animal models are the most relevant concerning physiology and the daily clinical 
routine, they allow to perform follow-up studies, in an intact animal in vivo, and they 
enable the use of all the techniques and measurements, which are used in the clinical 
practice, such as percutaneous coronary intervention techniques, echocardiography 
and magnetic resonance imaging. The disadvantage of large animal models could be 
the fact that the experimental process of MI induction takes place in healthy animals, 
which differs mainly from the complex and progressive development of human 
disease, influenced by many genetical and environmental factors. These differences 
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could play important role in the contrasting results regarding the effects of infarct 
size limiting drugs, since these interventions produced significant infarct size 
limiting effects in animal models, but failed in man [9].  
 
1.3 Reperfused and nonreperfused MI - Patophysiological background 
 
As it was emphasized in the review article of Pfeffer and Braunwald the 
prevalence of left ventricular remodeling and the consequent heart failure, adverse 
events and increased mortality can be best influenced by the limitation of the “initial 
insult” [2]. It was already demonstrated from the early animal experiments of MI, 
that restoration of blood flow facilitates myocardial salvage [3, 17]. According to the 
results of Garcia-Dorado et al., longer than 30 minutes occlusions result in 
exponential increase of infarct size, and could reach up to 75% of the infarct area of 
animals with permanent occlusion at 90 minutes [17]. In other words, in the absence 
of significant collaterals 120 minutes of occlusion results in a complete infarction, 
while the necrosis can be prevented within 30 minutes of occlusion. On the other 
hand the difference of collateral circulation among species should also take into 
account, since pigs are characterized by poor collaterals in contrast to the dog, which 
have well developed collaterals. In dogs nearly 50% of the myocardium at risk could 
be salvaged with reperfusion after 90 minutes [18].  In 1971 Maroko et al. described 
other factors that can influence infarct size beside the time from occlusion to 
reperfusion using open-chest dog MI models via the examination of the extent and 
magnitude of epicardial ST segment elevation. Certain factors can influence the 
balance between oxygen supply and demand. For instance the induction of 
tachycardia via the administration of isoproterenol results in a more intensive 
myocardial injury, in contrast to the administration of propranolol [19]. Myocardial 
reperfusion could result in reversible and irreversible injuries, due to oxygen derived 
free radicals and calcium overload. In the injured myocardial tissue platelet 
deposition is accompanied by the migration of neutrophils. This process is associated 
with coronary endothelial dysfunction, and the rapid entry of neutrophils occurs 
especially after reperfusion. According to Kloner four types of reperfusion injury 
could be observed in experimental animals: lethal reperfusion injury, referring 
reperfusion induced death of still viable cells, vascular reperfusion injury, which 
manifests as microvascular damage, stunned myocardium, which is demonstrated 
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through the contractile dysfunction of salvaged myocytes, and reperfusion 
arrhythmias, such as ventricular tachycardia or fibrillation [20]. Early reperfusion 
allows myocardial salvage, prevents the process of remodeling, left ventricular 
dilatation, heart failure and electrical instability [4], despite the above mentioned 
factors of reperfusion injury. In the cases of chronic occlusions, where no reperfusion 
occurs, the process of myocardial remodeling results in decreased survival through 
the increased prevalence of heart failure and malignant ventricular arrhythmias [2]. 
Since the difference in the prevalence of left ventricular remodeling, heart failure and 
mortality, myocardial infarcts with or without reperfusion represents different 
patophysiological and clinical entities. According to this fact the preclinical studies 
also should aim to point out this difference in animal models for the evaluation for 
both diagnostic methods and therapeutic approaches. 
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2. Aims 
 
There are five different types of acute MI, as it is already known even from 
the everyday clinical practice and guidelines [21]. Although several diagnostic 
approaches are available to aid more effective and oriented therapy, the 
patophysiological background, e.g. the presence or absence of reperfusion 
significantly influences this pursuit. The reperfused and nonreperfused MI have 
different outcomes [4] and could require the involvement of new biological 
therapeutic approaches, therefore feasible methods are required to provide 
information about myocardial viability for every clinical settings. Our main aim was 
to apply different reperfused and nonreperfused porcine models of MI and to 
evaluate them via electromechanical mapping (EMM), as an invasive diagnostic 
method for the detection of myocardial viability, regarding the different 
pathomechanism and location with the additional utilization of cMRI as a gold 
standard non-invasive method. Although the value of EMM has been already 
evaluated by several animal and clinical studies, they lack the systematic 
investigation of EMM in reperfused and nonreperfused MI models, using the same 
protocol. Partially, we investigated (1) the applicability of the different reperfused 
and nonreperfused MI models, (2) the relationship between the parameters of global 
left ventricular function and the UV, BV and LLS values, (3) the differences in the 
grouped UV, BV values according to the cMRI viability and transmurality results 
using the same regional segmentation. Finally, since EMM has limited diagnostic 
accuracy in the posterobasal region [22], we also induced MI in the territory of the 
Cx artery using coil embolization, in order to perform ROC analysis according to the 
different anatomical localizations (LAD or Cx). 
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3. Investigation of porcine MI models, implication of different occlusion 
methods 
 
3.1 Reperfused and nonreperfused MI - Experimental settings 
 
The different methods for the induction of myocardial necrosis result from 
different patomechanical processes in preclinical models while the reperfused and 
nonreperfused MI also have different outcomes [4]. The transient occlusion methods 
most frequently serve a platform to evaluate the effects of pharmacological agents in 
the prevention of infarct expansion and reperfusion injury. The time frame of 90 
minutes balloon occlusion allows still a small portion of the myocardium to be 
salvaged [3], this method is used most frequently in closed-chest large animal models 
[23-27], and were earlier induced by ligation techniques in open-chest models [3, 17, 
19]. 
The open chest methods allow both the utilization of permanent or temporary 
occlusions, via ligation [3, 28], vascular clamps [19], snare [29], hydraulic [30] and 
pneumatic occluders [31]. The direct visual control of hyperaemia at reperfusion and 
the measurement of contractile function [32], metabolic parameters [33] or gross 
morphologic details of cardiac ischemia in vivo [34] are the main advantages of these 
methods, although they are usually characterized by increased mortality and 
complication rates [11]. Inflammation and infections could occur more often [12], 
and they could induce increased surgical trauma. During the postoperative stage the 
scar tissue formation and the increased presence of air in the tissue layers could 
deteriorate cMRI image quality [13]. Hypothermia is widely used in open-chest 
methods, although it significantly could affect the infarct size [15]. Large animal 
models serve as candidates for the testing of novel minimally invasive heart surgery 
techniques, such as endoscopic approach of the internal mammary artery [35].  
The catheter-based minimal invasive interventional cardiology techniques 
allowed the wide application of the closed chest methods for the in vivo evaluation 
of MI and are preferable regarding the better survival rates, time and cost 
consumption [11]. Temporary occlusions can be achieved by the utilization of 
balloon inflation [23-27, 36] or application of balls with an attached filament [37] in 
the coronary artery. Permanent occlusion could be induced via embolization 
materials, e.g. graded microspheres [38], coils [39-41], foam sponge [42], agarose 
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gel beads [43], or application of endothelial electrical injury [44], heating of a 
thermosonde [45]. The main characteristics of these models are summarized in 
Appendix 1.  
 
3.2 Aims 
 
Despite the above mentioned large amount of data, the parallel evaluations of 
the different closed chest MI models are lacking. Therefore in the first part we 
investigated the differences in mortality and complication rates in the balloon 
occlusion and coil deployment methods. 
 
3.3 Study design 
   
MI was induced using either balloon occlusion (n=7) of the left anterior 
descending artery (LAD) for 90 minutes followed by reperfusion, or percutaneous 
embolization coil deployment (n=9) in the LAD (n=6) or the circumflex artery (Cx, 
n=3). The cMRI and EMM procedure were performed at the sixth day after the 
infarction induction procedure. 
  
3.4 Porcine MI models 
 
Anaesthesia was induced using intramuscular ketamine 15 mg/kg (10% 
Ketavet 100, Intervet International GmbH.) and xylazine 0.1 mg/kg (2% Primazin, 
Alfasan International B.V.) in sixteen domestic pigs weighing approximately 26 to 
38 kg. After the induction of anaesthesia the animals were intubated and ventilated, 
using Isoflurane 2% and Oxygen 2-3L/min. Vital signs and electrocardiogram were 
monitored continuously. Each animal received 150 mg amiodarone (Cordarone) 
before the procedure in order to avoid malignant ventricular arrhythmias. The main 
steps of the preparation of the animals are presented on Figure 1. Five French sheath 
and Amplatz 1 or 2 guiding catheters were used to perform coronary angiography of 
the left coronary system after the preparation of the right femoral artery. 
Unfractionated heparine (90 IU/kg) were administered intraarterially before the 
angiography. In the balloon occlusion group (Cross sail, Guidant, Santa Clara, CA) 
anterior infarction was produced by transient (90 min) occlusion in the LAD after the 
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origin of the first diagonal branch, followed by reperfusion. Complete coronary 
occlusion was confirmed by angiography (TIMI flow score=0), beside the ST 
segment changes observed on the ECG. The reperfusion in the balloon occlusion 
group was also detected via angiography. In the nonreperfused MI group the coil 
(VortX, Boston Scientific, Natick, MA, USA) was deployed either in the LAD after 
the first diagonal branch or in the proximal part of the Cx artery according to the 
coronary angiogram. The occlusion was confirmed by angiography (TIMI flow 
score=0). Each animal received 100 mg magnesium and 1000 IU unfractionated 
heparine every thirty minutes during the balloon occlusion procedure. After the 
embolization procedure occlusion occurred within minutes. In the first hour of 
recovery prophylactic antibiotics (Shotapen, Virbac S.A.) were given intramuscularly 
and all animals were monitored for vital signs and signs of uncomfort. During the 
first week all animals in the LAD balloon group received Aspirin 100 mg daily. All 
animal experiments were carried out according to the regulations of the local 
institutional ethical committee and the Guide for the Care and Use of Laboratory 
Animals. 
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Figure 1. Illustration of the preparation of animals before the induction of MI. The 
upper part represents the positioning of the animal before the angiography; the 
bottom picture represents the inserted sheat in the right femoral artery. 
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3.5 Results  
 
3.5.1 Mortality rates  
 
The EMM and cMRI information of five animals in the LAD balloon group 
and 3-3 animals in the LAD and Cx coil groups were available at the sixth day for 
statistical analysis.  Three animals from the LAD coil group (mortality rate: 50%) 
and 2 animals from the LAD balloon group (mortality rate: 28.57%) died during the 
procedure, at the time of occlusion or right after balloon deflation due to fatal 
ventricular fibrillation. All animal survived in the Cx coil group, although one animal 
showed signs of pulmonary oedema on the fifth day post MI. The overall mortality 
rate was 31.25%.    
 
3.5.2 Occurrence of malignant arrhythmias 
 
Despite all animals received amiodarone as a premedication the occurrence of 
ventricular arrhythmias were frequent, and were treated by 150J DC shock and 
additional intravenous magnesium. The rates of non-fatal ventricular arrhythmias 
were the following: 28.57% in the LAD balloon group, 33.33% in the LAD coil 
group. Arrhythmia was not observed in the Cx coil group. 
 
3.5.3 Occurrence of other perioperative complications 
 
In the LAD coil group one animal suffered from abdominal haemorrhage 
according to the post-mortem autopsy, which we referred as a surgical complication 
and vascular rupture after the preparation of the femoral artery. During the coil 
deployment procedure we observed extravasation on coronary angiography, which 
ceased after additional coil deployment in one animal in the Cx coil group. 
 
 
 
 
 
 
 15 
3.6 Discussion 
 
The balloon occlusion model represents the features of reperfused MI [23, 25] 
and furthermore demonstrates the changes which are consistent with the clinical data 
in the cases of primary percutaneous coronary intervention in acute coronary 
syndromes. Embolization materials, e.g. coils are used to induce permanent 
occlusion of the coronary artery and these methods resemble the features of 
nonreperfused MI [40]. The sign of no-reflow phenomenon on the cMRI images 
represents the phenomenon of microvascular obstruction, which predicts increased 
left ventricular remodeling [46] and correlates with a higher rate of cardiovascular 
events in the first two years after MI [47]. It is detectable in the cases of reperfused 
myocardial infarcts and was present in our experiments also, in the LAD balloon 
group. As mentioned before no reperfusion occurs in the permanent occlusion 
models, and the wavefront phenomenon of myocardial necrosis is complete [3], 
serving as a good approach for the clinical situation where we are not able to achieve 
revascularization, e.g. in no-option patients. The coil deployment method [13, 39-41, 
48], allows precise positioning of the occlusion in the coronary artery, to produce 
similar area at risk, and moreover produces no artefacts on cMRI images, due to its 
MRI compatible material. This model closely resembles to the human course of 
atherosclerotic disease superimposed by thrombus formation [39]. Both models 
provide appropriate platform for the evaluation of novel regenerative therapeutic 
approaches such as growth factor and cell therapies. Recent metaanalysis of van der 
Spoel et al. demonstrated that permanent occlusion models are associated with more 
improvement, than the transient occlusion models after cell therapy [49], which 
could result from the larger infarct expansion, occurring without reperfusion and 
myocardial salvage in contrast to the temporary occlusion models. This result also 
emphasizes the involvement of both models in preclinical studies. The mortality rates 
in our MI groups did not differ significantly in cases of LAD occlusion using either 
balloon or coil deployment, producing similar area at risk. Death most frequently 
resulted from ventricular fibrillations, resistant against repeated DC shocks and 
antiarrhythmic therapy. Mortality rate could vary between 20 and 50% in different 
catheter based techniques [13, 26, 36, 40, 42, 43, 50] and were 33.33% and 28.57% 
in our practice in the coil deployment (nonreperfused) and balloon inflation 
(reperfused) induced groups, respectively. It is well known from the literature, that 
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the reversibility or irreversibility of myocardial injury and the size of myocardial 
infarction depend on the time course [3, 32] and localization of occlusion [28]. 
Usually the large diagonals are playing important landmark role on the LAD during 
the positioning of the occlusion. On the other hand Huang et al. raised a practical 
new approach in open chest models, since they used the whole length of LAD as a 
landmark, rather than its diagonal branches to produce similar area at risk [51]. In 
our experience both the 90 minutes balloon occlusion and the coil deployment in the 
LAD produced similar myocardial infarct size, using diagonal branches for 
landmarks in both model. The reproducibility of infarct size plays an important role, 
since in preclinical studies of stem cell therapy usually results in a left ventricular 
ejection fraction improvement of less than 10% [49]. The exact angiographic 
determination of similar occlusion sites ensures this demand. 
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4. Determination of global and regional left ventricular function in porcine 
MI models: invasive and non-invasive modalities  
 
 4.1 Introduction 
 
Early successful reperfusion therapy results in myocardial salvage within the 
area at risk, therefore decreases infarct size, ventricular wall stress, dilatation and the 
prevalence of left ventricular remodeling and congestive heart failure [2]. The degree 
of infarct expansion determines the intensity of remodeling, together with the process 
of infarct healing and the consequent changes in ventricular wall stresses. Early 
revascularization attenuates this process. The survival after MI is influenced 
negatively by the left ventricular end-diastolic and end systolic volumes, and 
positively by the ejection fraction [52]. Cardiac MRI played important role in the 
evaluation of the cardiac performance from the mid-1980s [53], due to its high 
spatial and temporal resolution. Both the values of global and regional left 
ventricular function are measured in end-systole and end-diastole. The above 
mentioned high spatial and temporal resolution allows the exact quantification of 
regional wall thickness, systolic wall-thickening (absolute or percentual values). The 
preserved wall thickness is a good indicator of myocardial viability in chronic 
myocardial infarctions [54].  In patients with heart failure the measurement of 
ejection fraction and left ventricular volumes via echocardiography, contrast 
ventriculography, radionuclide ventriculography and cMRI are not interchangeable 
[55]. Echocardiography and contrast ventriculography usually overestimates the 
value of ejection fraction. Recent evaluation of the effects of stem cell therapy in 
large animal models indicated, that stem cell therapy improves left ventricular 
ejection fraction by 7,5% [56]. This fact highlights the importance of the exact 
evaluation of left ventricular function, before biological therapies and during the 
follow-up period.  
In vivo mapping and navigation combined with an electrophysiological 
catheter to perform left ventricular electromechanical mapping (EMM) was first 
introduced by Ben-Haim et al in 1996 [57]. Since then EMM was widely 
investigated regarding the diagnostic accuracy of this method in both preclinical and 
clinical settings of ischemic cardiomyopathy [22, 58] and in experimental non-
ischemic cardiomyopathy [59]. EMM utilizes ultralow magnetic field energy to 
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determine the exact place of the catheter within the left ventricle [57], allowing to 
achieve a real-time three dimensional map of the left ventricle. These maps can 
provide data about global left ventricular function (end-systolic, end-diastolic, stroke 
volumes, ejection fraction). The special sensor-tipped diagnostic catheter provides 
information of the local electrical activity, and the amplitude of this electric signal 
was shown to correlate well with the extent of myocardial ischemia [60]. The 
systematic acquisition of unipolar (UV), bipolar voltage (BV) and linear local 
shortening (LLS) data results in a three-dimensional map on the endocardial surface, 
which represents the left ventricle. Both the UV and BV value represent in vivo 
endocardial electrical signals, which could indicate myocardial viability. According 
to the definition of Kornowski et al., the LLS value “quantifies regional wall motion 
by calculating the fraction of linear distances of each endocardial point from its 
neighbouring points at end-systole, relative to end-diastolic distances” [22]. 
Decreased voltage and LLS values indicate myocardial necrosis. Both the global and 
the regional data provided by EMM were investigated in order to validate against 
other methods, including echocardiography [61], ventriculography [62, 63], 
scintigraphy [64-67], positron emission tomography [65, 67] and cMRI [68]. The 
evaluation of both viability (UV and BV) and regional wall motion abnormalities 
(LLS) could be performed side by side. As known from the previous literature FDG-
PET could identify preserved metabolism, and therefore the areas of viable 
myocardium [69]. EMM is able to identify these regions as “electrically viable” 
myocardium, according to Koch et al [70]. According to these investigations the 
potential positive effect of revascularization could be estimated by the UV value, 
measured before percutaneous coronary intervention in patients, since the measured 
UV values exhibited good correlation with the recovery of regional wall motion 
assessed by ventriculography [70]. The parallel evaluation of voltage values and LLS 
could allow the detection of hibernated myocardium, which is indicated by preserved 
electrical and decreased LLS values [64]. Despite the above mentioned results 
regarding left ventricular function via EMM, especially the voltage and LLS values 
were not evaluated parallel by the regional cMRI data in reperfused and 
nonreperfused MI models.  
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  4.2 Aims  
 
 In the second part, we determined the variables of global and regional left 
ventricular function via EMM and cMRI. The latter could serve as a gold standard 
both in measuring the variables of global and regional left ventricular function, while 
these characteristics of EMM were not evaluated in detail in different large animal 
MI models.  
 
 4.3 Methods 
 
4.3.1 Electromechanical mapping procedure 
  
After the previously delineated anaesthetical procedures and the induction of 
reperfused and nonreperfused MI (Chapter 3.4) EMM (NOGA, Biosense Webster, 
Cordis, Johnson and Johnson, Diamond Bar, CA) was performed on the sixth day, 
using 8F NOGA diagnostic catheter via left transfemoral approach. The mapping 
system consists of a triangular pad, inducing ultralow magnetic field, a reference 
catheter, a diagnostic catheter and a workstation, allowed both for online and 
offline data processing. All animals received 90 IU/kg unfractionated heparin 
before the mapping procedure. The diagnostic catheter was introduced retrogradely 
through the aortic valve into the left ventricle. The first points were acquired from 
the apex and the basis of the left ventricle using fluoroscopy, followed by 
systematic point acquisition process in the whole left ventricle, with a fill threshold 
of 15 mm. This approach allows the accurate detection of the apex to ensure the 
correct characterization of the maps using detailed segmentation of the left 
ventricle. The average duration of the mapping procedure was 60 minutes. Three 
dimensional colour-coded maps were derived in each animal, containing the values 
of UV, BV and LLS after the completion of the mapping procedure. The inner 
points and points located in the left atrium or recorded during ST elevation or 
without the standard eligibility criteria, as described by Gepstein et al. [71, 72] 
were deleted from the maps using visual assessment and moderate automated 
filtering processes. The maps of UV, BV and LLS values were analysed using the 
12 segment bull’s eye images, which were further divided into additional segments 
in order to be able to perform a more detailed comparison to the cMRI data. The 
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long axis of the left ventricle was divided into apex, midventricle and base 
consisting 20%, 40% and 40% of the long axis respectively. These parts were 
divided into four regions: anterior, septal, inferoposterior and lateral, each divided 
furthermore into two equal regions in the anterior, lateral and inferoposterior walls 
and into three equal regions of the septal wall (Figure 2.). The acquired images 
according to the different imaging modalities are demonstrated on Figure 3., the 
upper part represents one animal from the LAD balloon group, the lower part 
represents one animal from the Cx coil group. During the acquisition of 
endocardial points we did not experience any lethal complications; however the 
excessive manipulation, especially at the apex, and at the side of the infarcted and 
thinned myocardium could lead to perforation and pericardial tamponade 
formation. As a minor complication one animal evolved ventricular tachycardia in 
the LAD balloon group, and it was terminated by magnesium and beta-blocker 
administration. 
 
 
 
 
Figure 2.  Bull’s eye segmentation of the left ventricle for EMM and cMRI 
analysis, the apical, mid and basal part contains 9-9 segments. 
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Figure 3. Demonstration of the infarct areas according to the different localizations 
A: Coronary angiogram at the time of occlusion: balloon inflation in the LAD, coil 
deployment in the Cx 
B: Long and short axis cMRI late enhancement images 10 minutes after contrast 
administration 
C: EMM UV map, LAO and bull’s eye view 
 
 
4.3.2 Cardiac MRI acquisition and analysis   
 
     Cardiac MRI (Siemens, 1.5 T) was performed in anaesthetized animals in the 
supine position with electrocardiographic gating and breath-hold acquisitions, using 
flexible cardiac phased array coil, right after the EMM procedure. In order to 
improve the quality of images 100% oxygen was administered with positive pressure 
during the breath-hold acquisitions. For the late enhancement contrast images 
Gd(DTPA-BMA) (Omniscan) was administered 0.15 mmol/kg intravenously. If 
needed, the animals also received metoprolol 3 mg intravenously for heart rate 
control to enhance image quality. Short and long axis movie and delayed 
enhancement images were acquired following the basic scout imaging procedure 10 
minutes after contrast injection. The acquisition parameters were the following: slice 
thickness 8 mm, field of view 300x206 mm, image resolution 256x192 pixels, flip 
angle 65 degrees, echo time 1.1 ms, repetition time 38.75 ms. Analysis regarding 
viability was captured on the short axis late enhancement images 10 minutes after 
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intravenous contrast administration (imaging parameters: slice thickness 8 mm, field 
of view 300x206 mm, image resolution: 192x132 mm, flip angle 50 degrees, echo 
time 1.14 ms, repetition time 465 ms). The inversion time was selected at each 
acquisition on the basis of the maximal zeroing of remote left ventricular 
myocardium. Cardiac MRI data were analysed using MASS software (Medis, NL), 
version 6.1.6. The epicardial and endocardial borders were defined in the end-
systolic and end-diastolic phases of the short axis movie to capture data about the 
global left ventricular function (ejection fraction, stroke volume, end-diastolic 
volume, end-systolic volume). Detailed information was yielded about segmental 
end-systolic (ESWT) and diastolic wall thickness (EDWT) and regional wall motion 
characteristics via another derived value, wall thickening (WT, subtracting EDWT 
from ESWT, expressed as percentage of EDWT), using a 9 segment per slice model 
in order to be able to compare with the EMM data. The value of mean signal 
intensity (SI, au) and infarct transmurality (T%, as percentage of the whole wall 
thickness) was investigated using the same segmentation protocol on the acquired 
short axis late enhancement images. Increased signal intensity (late enhancement) 
represents infarcted areas. Full-width-half-maximum (FWHM) method was used to 
detect infarct size [73].   
 
 
 4.3.3. Statistical analysis 
 
All results are presented as a mean ± standard error of mean (S.E.M.). Bland-
Altman plots were reconstructed using MedCalc statistical software (version 12.3). 
The data regarding segmental derived wall motion parameters (EDWT, ESWT, WM 
and WT) and UV, BV, LLS were evaluated by Pearson correlation in a segment per 
segment fashion. For the statistical analysis SPSS software package, version 16.0 
was used.   
 
 
 
 
 
 
 23 
4.4 Results 
 
4.4.1 EMM acquisition data 
 
The average number of acquired EMM points was 138±30 per animal, during 
the on- and offline post processing analysis 38±19 and 24±7 points were deleted. The 
final number of eligible points was: 80±12. Segments containing less than two points 
were excluded from the evaluation; accordingly 166 segments (68.1%) were 
available for the statistical analysis. 
 
4.4.2 Global left ventricular function and viability vs. EEM data 
 
The average values of UV, BV, LLS, EMM and cMRI derived EF, EDV, 
ESV and SV are demonstrated in Table 1. The correlation between the EMM derived 
SV and the UV and BV values were significant (r=0.605, p=0.049, and r=0.671, 
p=0.024 respectively). The correlation was significant between the UV values and 
the EMM and cMRI derived EF (r=0.603, p=0.05; r=0.641, p=0.034 respectively). 
The correlation between the LLS values and the EMM derived EF also yielded 
significance (r=0.604, p=0.049). Furthermore the correlation between the average 
UV value and the left ventricular end-diastolic mass (LVmassED) was significant 
(r=0.755, p=0.007). 
 
EMM 
data 
UV (mV) BV (mV) LLS (%) EF (%) EDV (ml) ESV (ml) SV (ml) 
LAD 
balloon 
6.48±0.32 1.96±0.37 8.06±1.61 35.95±4.24 71.89±1.77 45.96±2.57 26.07±3.45 
LAD 
coil 
7.51±0.48 2.98±0.42 9.18±3.61 39.54±8.18 77.55±4.25 46.42±4.26 30.96±7.34 
Cx coil 6.97±0.96 2.26±0.33 5.44±0.92 24±6.17 88.27±8.31 66.72±1.76 22.34±7.32 
 
cMRI data EF (%) EDV (ml) ESV (ml) SV (ml) 
Infarcted tissue 
(g) 
Infarcted tissue 
(%) 
LAD 
balloon 
31.16±3.99 69.25±9.27 47.07±5.23 22.18±5.62 13.09±1.52 19.2±1.43 
LAD coil 46.43±4.52 82.39±3.37 44.41±5.6 37.98±2.45 13.07±0.63 17.33±0.67 
Cx coil 28.7±3.55 61.82±7.81 43.58±3.75 18.24±4.44 8.17±0.79 12.33±0.67 
 
Table 1. The average values ± .S.E.M. of main variables in the EMM and cMRI data 
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There were no significant differences in the three groups regarding the 
absolute extent of myocardial infarcts. On the other hand the percentage of the 
infarcted area differed significantly in the LAD balloon (19.2±1.43%) and in the Cx 
coil group (12.33±0.67%) by one-way ANOVA and Tukey HSD post hoc test (LAD 
balloon vs. Cx coil, p=0.011).   
The method of Bland-Altman analysis was used to display the average 
difference and limits of agreement between the cMRI values, as a reference and the 
EMM values (Figure 4.).  
 
 
Figure 4. Bland-Altman plots of left ventricular EDV, ESV, EF, and SV 
derived from EMM and cMRI measurements from the LAD balloon, LAD coil and 
Cx coil groups.  
 
4.4.3 Segmental wall motion and viability analysis 
 
The relationship between the segmental average UV, BV and LLS values and 
EDWT, ESWT, WT and SI, T% was furthermore investigated. Data are 
demonstrated through the results of one animal in each group. The following 
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correlations were significant between the EMM derived (UV, BV, LLS) and cMRI 
derived (EDWT, ESWT, WT, SI and T%) values. 
 
I. LAD balloon group: the correlation was significant between the segmental average 
UV value and the segmental average SI and T% value (r=-0.571, p=0.021 and r=-
0.631, p=0.009, respectively). The segmental average BV value also showed good 
correlation with both viability parameters (r=-0.503, p=0.047 and r=-0.586, 
p=0.017), Figure 5.  
 
 
Figure 5. Correlation between segmental average UV, BV and T% in the LAD 
balloon group 
 
II. LAD coil group: only the BV value exhibited statistically significant correlation 
with the segmental average SI value (r=-0.432, p=0.05).  
 
III. Cx coil group: the average UV value also showed good correlation with the SI 
and T% values (r=-0.818, p <0.001, r=-0.778, p <0.001) and furthermore the 
relationship between the UV value and the EDWT and ESWT values was significant 
(r=0.782, p <0.001, r=0.694, p=0.003, Figure 6.). 
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Figure 6. Correlation of average UV and EDWT, ESWT in the Cx coil group 
 
 
4.5 Discussion 
 
The agreement between the cMRI and EMM derived data concerning left 
ventricular function is moderate according to previous preclinical and clinical studies 
[62, 63, 70, 74-76]. In our study the EMM and cMRI derived values of global left 
ventricular function exhibited good agreement, but did not reached statistical 
significance in the correlational studies (data not shown). The main advantage of 
EMM is that it can be integrated to hemodynamical equipments and provides in vivo, 
online data about left ventricular global and regional function, without the significant 
increase of radiation dose. The large animal models allow investigating the 
electromechanical properties of animals with an extremely low EF with more 
increased scar tissue extent. The relationship between the global left ventricular 
parameters, especially between the EF, SV and the average UV values indicates a 
good diagnostic and may even prognostic impact of these parameters, since a more 
extended myocardial damage results in lower average voltage values [74, 77]. This 
could result from the mathematical average derived from both the viable and 
infarcted myocardial tissue; on the other hand it also could depend on left ventricular 
volume, wall thickness, degree of remodeling and extent of MI [77]. These factors 
affect remote areas outside the area of interest; therefore they influence the UV 
value, since it contains far-field components [78, 79]. The diagnostic accuracy of the 
LLS value highly depends on the homogeneity and number of points, and is derived 
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from the distances of the surrounding points in end-systole and end-diastole, partly 
neglecting the wall thickening during systole and is also influenced by passive 
motions of the heart [62, 79, 80]. In our study the LLS value showed moderate 
correlation with the left ventricular EF, and was not able to exhibit significant 
relationship with the regional EDWT, ESWT and WT values. The utilization of this 
parameter may be useful for the overall map analysis, and especially at the area of 
interest together with the voltage values, to identify discordant areas with preserved 
voltage and decreased LLS values. The regional left ventricular function can be 
characterized using the cMRI derived EDWT, ESWT and WT values, which are 
indicating the presence and progress of postinfarction remodeling. Our data suggests, 
that the UV and BV values may are also reflecting these processes properly. The 
segmental average voltage values exhibited good correlation with the average values 
of signal intensity and transmurality and furthermore this analysis served as a 
feedback, to prove the reliability of our data. 
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5. Evaluation of myocardial viability in porcine MI models  
 
5.1 In vivo infarct quantification - imaging techniques 
 
The exact quantification of the myocardial damage, e.g. the extent of necrotic 
tissue has high prognostic value and is a very crucial endpoint in preclinical studies; 
therefore several in vitro and in vivo methods were developed and used to fulfil this 
requirement. The earliest studies applied post-mortem histological investigations [3, 
28, 81], changes in necroenzimes [19, 29], isometric contractile force using strain 
gauge technique [82] or measured regional wall thickening dynamics via ultrasonic 
crystals positioned on the walls of the left ventricle [83] and finally changes in 
electrocardiography [19] or local changes in temperature could also be measured 
[34]. The non-invasive imaging techniques could provide more exact quantification 
of the infarcted area, such as scintigraphy (SPECT) [84], positron emission 
tomography (PET) [85], computer tomography [86] or echocardiography [87] and 
furthermore could indicate reversible injuries also [88]. In the last decades cMRI has 
been proved to be a feasible and accurate non-invasive method for the detection and 
characterization of the infarcted and viable areas, and moreover has high prognostic 
value [89, 90]. The so called late or delayed enhancement phenomenon 10 minutes 
after intravenous injection of extracellular contrast materials (Gadolinium-
diethylenetriamine pentaacetic acid - Gd-DTPA) indicates myocardial viability both 
in acute and healed MI and provides high localizational accuracy, regarding even the 
direct visualization of the transmural extent of MI [91, 92]. The background of this 
phenomenon is partly understood and in acute MI it could result from myocyte 
necrosis and consequent sarcomere membrane rupture, which prolongs the diffusion 
of contrast molecules [89], therefore the volume of distribution of Gd-DTPA 
increases. Extracellular contrast agents could overestimate the infarct size in the 
hyperacute stage of MI, although this phenomenon was not observed at eight weeks, 
which could be explained by the process of infarct shrinkage [92]. In the hyperacute 
phase the peripheral region represents a reversibly injured myocardium and produces 
transient enhancement, which resolves during the subacute stage. In the cases of 
chronic MI delayed enhancement could result from the delayed wash-in and wash-
out kinetics of contrast agents in the scar tissue, and the increased volume of fibrotic 
 29 
tissue [93]. This method was used frequently in several porcine MI studies and in our 
practice, as it is demonstrated in Figure 7.  
 
Figure 7. Cardiac MRI images of the infarct areas according to the different 
localization in porcine via the phenomenon of late enhancement imaging 10 minutes 
after contrast administration. All images were derived of one given animal from the 
group of balloon occlusion in the LAD and from the group of coil deployment in the 
Cx artery. 
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A: Coronary angiogram at the time of the coronary artery occlusion: balloon inflation 
in the LAD (upper image), coil deployment in the Cx (bottom image).  
B: Long axis late enhancement images 10 minutes after contrast administration after 
the occlusion of the LAD (upper image, arrows indicate the late enhancement 
phenomenon in the septal and anterior wall) and the Cx artery (bottom image, arrows 
indicate the late enhancement phenomenon in the lateral and posterior wall).   
C: Short axis late enhancement images 10 minutes after contrast administration. The 
upper sequence of pictures represents the consequent images of the left ventricle 
after balloon occlusion of the LAD. The bottom sequence of pictures represents the 
consequent images of the left ventricle after coil deployment in the Cx. (Arrows 
indicate the late enhancement phenomenon.)   
 
 
Furthermore cMRI is the first non-invasive method that has the possibility to 
differentiate between reperfused and nonreperfused myocardial infarctions in the 
acute setting [94]. The recently developed combination of intravascular and 
extracellular Gadolinium-chelates raised the possibility to distinguish between acute 
and chronic MI [95] in open chest porcine models producing transient 120 min. 
occlusion of the LAD. Intravascular Gadolinium-chelates produce delayed contrast 
enhancement only in acute myocardial infarcts, due to the retain of intravascular 
contrast agents in the remodelled microvessels and the poor vascularisation and 
perfusion of scar tissues [96]. Also, recent studies of Kirschner et al. demonstrated 
also the value for the differentiation between acute and chronic infarcts in a closed 
chest, 180 minutes balloon occlusion model, since Gd(ABE-DTTA), which has 
intravascular properties and produces no delayed enhancement in chronic infarcts 
[97, 98]. 
The above mentioned properties of cMRI made it plausible to be the 
determinant of myocardial infarct size in animal studies [13, 99] and also raised the 
possibility of direct tracking stem cells after therapeutic interventions [100-102]. The 
measurement of infarct size is based on the extent of increased signal intensity; 
however several methods are available for the quantification of delayed enhancement 
images. From the above mentioned methods the utilization of the signal intensity 
percent infarct mapping beside the full-width-half-maximum method is accurate for 
infarct size quantification, and they were superior to remote plus standard deviation 
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thresholded late enhancement images for infarct size determination, validated against 
the gold standard triphenyl-tetrazolium-chloride (TTC) staining ex vivo [103]. 
Recently the signal intensity percent infarct mapping was also validated in vivo 
against remote plus standard deviation thresholded delayed enhancement images in 
vivo in a porcine closed chest balloon occlusion model and requires clinically 
acceptable scanning time [104]. In conclusion the utilization of cMRI in large animal 
models is accurate and could be feasible for follow-up studies, therefore decreases 
the necessary number of animals.  
The availability of integrated magnetic resonance scanner within the 
catheterization laboratory is limited at this time; on the other hand the diagnostic 
procedures need to be accurate and fast, providing online data about myocardial 
viability. Recently EMM has been also utilized as an invasive, catheter-based method 
to measure myocardial viability and regional left ventricular function [22, 105]. The 
values of UV and BV allow determining the myocardial viability, raising even the 
possibility to gain information about the transmural extent of necrosis [68, 76]. The 
LLS value provides information about local regional contractility, therefore the 
infarcted areas are characterized by reduced values, and these values can be matched 
with the reduced voltage values [58]. The safety and feasibility of EMM has been 
proved in acut and chronic MI models to be able to identify and localize viable 
myocardial tissue and scar tissue [22, 58]. EMM has the unique opportunity, to be 
used directly in the catheterization laboratory, and also raised a unique way for local 
therapeutic approaches, e.g. administration of cells [106] or other biological 
materials [107, 108], and has been utilized for intramyocardial injections in several 
animal and clinical studies [109, 110].  
 
5.2 Aims 
 
The intramyocardial injection of cells or growth factors is the unique and 
main advantage of EMM. This feature requires the exact determination of the 
necrotic area, the transitional zone and viable tissue. Cardiac MRI serves as a gold 
standard regarding myocardial viability among the non-invasive methods due to its 
high spatial resolution, concerning especially the transmural extent of necrosis. The 
diagnostic features of EMM were investigated in accordance to the results of cMRI 
regarding myocardial viability. 
 32 
5.3 Methods 
 
The design of experiments and the methods, utilized during the evaluation of 
myocardial viability are reviewed in Chapter 3.4, 4.3.2 and 4.3.1. Briefly, six days 
after the induction of MI, via balloon occlusion or coil deployment in the LAD, or 
coil deployment in the Cx, cMRI and EMM examinations were carried out. The late 
enhancement phenomenon indicating the presence and transmural extent of 
nonviable tissue were evaluated according to the above described segmentation 
protocol (Figure 2.) 10 minutes after contrast administration. During the EMM 
procedure the values of BV and UV represented the presence or absence of viable 
tissue, since the measurement of low voltage values indicates scar tissue. The values 
of LLS were also evaluated, presenting the characteristics of local wall motion. The 
same segmentation protocol was used as described above to be able to perform a 
segment by segment analysis. 
 
5.3.1. Statistical analysis 
 
All results are presented as a mean ± standard error of mean (S.E.M.). Data 
regarding segmental voltage and LLS values were grouped according to the cMRI 
viability data into three groups, segments containing transmural late enhancement 
(increased signal intensity more than 50 % of the whole wall thickness), 
subendocardial late enhancement (increased signal intensity in less than 50 % of the 
whole wall thickness) and viable tissue (absence of increased signal intensity). These 
groups were analysed by one-way analysis of variance (one-way ANOVA) and the 
Tukey HSD test was employed for post hoc comparison. Receiver operator 
characteristic (ROC) analyses were used for the determination of the predictive value 
of EMM parameters compared to the cMRI acquisition. The p value of less than 0.05 
was considered statistically significant at each analysis. For the statistical analysis 
SPSS software package, version 16.0 was used.   
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5.4 Results 
 
5.4.1 Transmural distribution of scar area 
 
The segmental average UV, BV and LLS values were grouped according to 
the cMRI transmurality data as segments containing transmural, subendocardial late 
enhancement or viable tissue. After the evaluation using one-way ANOVA, which 
showed significant difference between the three groups, Tukey HSD post hoc tests 
were carried out, which yielded significantly decreased UV and BV values in the 
segments with transmural and subendocardial late enhancement than in the viable 
areas, and significantly decreased LLS values in the segments with transmural late 
enhancement, than in viable segments as demonstrated in Fig. 8A.  
 
             
Figure. 8.  
A: Grouped analysis using one-way ANOVA and Tukey HSD post hoc test of the 
UV, BV and LLS segmental average values using the overall data, * indicates p 
values <0.05, bars represent the average values of UV, BV and LLS of segments 
characterized by transmural, subendocardial late enhancement or viable myocardial 
tissue on cMRI images, respectively. 
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B: Grouped analysis using one-way ANOVA and Tukey HSD post hoc test of the 
UV, segmental average values in the three animal groups, * indicates p values <0.05, 
bars represent the average values of UV values of segments characterized by 
transmural, subendocardial late enhancement or viable myocardial tissue on cMRI 
images, respectively. 
 
 
We also performed one-way ANOVA tests according the three animal groups, the 
results are summarized in Table 2., and Figure 8B. Segments with subendocardial 
and transmural late enhancement had significantly less UV values, than the viable 
segments in all groups. In the case of the BV value this phenomenon was only 
present in the LAD balloon group. 
 
 
Viable tissue 
Subendocardial 
late 
enhancement 
Transmural late 
enhancement 
UV (mV) 8.41±0.27 6.73±0.33 * 5.81±0.28 * 
BV (mV) 2.77±0.19 1.99±0.18 * 1.03±0.16 * 
LLS (%) 10±0.83 6.56±1.31 3.92±1.73 * 
UV (mV) LAD balloon 7.64±0.33 6.5±0.26  * 5.39±0.32 * 
LAD coil 8.96±0.56 6.97±0.46 * 5.97±0.5  * 
Cx coil 9.57±0.53 6.06±0.61 * 5.54±1.07 * 
BV (mV) LAD balloon 2.2±0.26 1.76±0.24 0.7±0.13  * 
LAD coil 3.65±0.39 2.42±0.35 1.36±0.28 * 
Cx coil 2.8±0.35 1.82±0.3 1.68±0.8  * 
 
Table 2. One-way ANOVA according to the overall data from all animal groups 
(upper third part), and the UV and BV values of the LAD balloon, LAD coil and Cx 
coil groups, * indicates p<0.05, in cases of viable tissue vs. transmural late 
enhancement, and viable tissue vs. subendocardial late enhancement. 
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5.4.2 ROC analysis of cMRI and EMM data   
 
Cardiac MRI for determining myocardial viability is a well tested gold 
standard method. We investigated the indicative capacity of the segmental average 
UV, BV and LLS values against cMRI segmental average signal intensity and 
transmurality using ROC analysis. First we examined the indicative value of UV, BV 
and LLS overall in the three animal group. The ROC curves were constructed to 
compare the subendocardial late enhancement vs. viable tissue and transmural late 
enhancement vs. viable tissue. The results are summarized in Figure 9. and Table 3. 
The AUC for the UV value was 0.657 (p=0.007), 0.783 (p<0.001), for the 
comparison of subendocardial and transmural late enhancement with normal tissue, 
for the BV value AUC was 0.551 (p=0.378), 0.824 (p<0.001), for the same 
diagnostic settings, respectively.  
 
 
Subendocardial late enhancement vs. normal tissue 
 AUC  95% CI  SEM  P value  
UV  
BV  
LLS  
0.657  
0.551  
0.623  
0.552-0.763  
0.442-0.661  
0.515-0.731  
0.054  
0.056  
0.055  
0.007  
0.378  
0.035  
 
Transmural late enhancement vs. normal tissue 
 AUC  95% CI  SEM  P value  
UV  
BV  
LLS  
0.783  
0.824  
0.642  
0.704-0.861  
0.749-0.9  
0.534-0.750  
0.04  
0.038  
0.05 
<0.001  
<0.001  
0.009  
 
Table 3. Main parameters of the ROC curves 
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Subendocardial late enhancement vs. viable tissue        Transmural late enhancement vs. 
viable tissue 
                  Figure 9. ROC curves from the overall data of all animal groups 
 
 
We also evaluated the possible differences between the accuracy regarding the two 
distinct infarct areas, namely at the territory of the LAD and Cx using ROC curve 
analysis. The characteristics of the ROC curve are summarized in Table 4. and 
Figure 10. The AUC for the UV value was 0.691 (p=0.037), 0.809 (p=0.002), in the 
LAD balloon and coil groups and 0.855 (p<0.001), 0.864 (p=0.001) in the Cx coil 
group for the subendocardial and transmural late enhancement vs. normal tissue, 
respectively. The BV value also expressed good diagnostic accuracy in the LAD 
balloon and coil group (subendocardial scar vs. normal tissue AUC=0.687, p=0.041, 
transmural late enhancement vs. normal tissue AUC=0.853, p<0.001), and failed to 
demonstrate significant diagnostic efficacy in the Cx coil group. 
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Figure 10. Detailed ROC analysis, according the different infarct areas using the 
segmental average UV, BV, LLS values 
 
 
 
Table 4. Main characteristics of the ROC curves of different territories 
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 5.5 Discussion  
 
The UV value was significantly decreased in segments containing 
subendocardial or transmural scar tissue according to our results, and this 
phenomenon was reproducible in different localizations also. During the ROC 
analysis the UV value provided good diagnostic accuracy and this result also seemed 
to be independent of the localization of the infarcted area. Although the 17-segment 
model is widely used and accepted in the human cMRI diagnostics, [111] the 
detailed segmentation allowed to perform a more detailed analysis in all animals. The 
basal, mid- and apical region of the heart was tested equally in 9-9 segments, and this 
model allowed minimizing misalignments during the anatomical matching to the 
cMRI images. All analyses were performed using this segmentational protocol. The 
number of segments with eligible number of points were 68,1%, this factor may 
influenced our data, on the other hand in case of the 12 segment model we only had 
to exclude 12 segments (8,3%), and similarly the number of acquired and eligible 
points were consistent with other data [61]. Despite the slight overestimation of the 
infarct area by delayed enhancement cMRI imaging, it was feasible for the segmental 
comparison, as a widely accepted and used method for myocardial viability [89, 92]. 
Myocardial segments characterized by 50% or less extent of hyperenhancement on 
delayed enhancement cMRI were termed as segments with subendocardial scar tissue 
in our porcine model. This classification was widely used in previous clinical 
assessments of EMM [68, 76], and this value predicts properly the positive effect 
after planned revascularization procedures [90]. Wolf et al. demonstrated good 
discriminative capacity of BV value in a dog model of MI with different 
transmurality using histopathological analysis, our results also demonstrate this 
discriminative capacity for the UV and BV value, on the other hand we used a less 
detailed characterization for the transmurality (50-100%, 50-0% or viable tissue), but 
in a more detailed segmental distribution of the whole left ventricle [105]. The 
present study demonstrates this significant discriminative capacity of EMM both in 
the LAD balloon and LAD coil groups for the UV value.   
The main aim of ROC analysis was to investigate the differences in the 
diagnostic efficacy of EMM, variables in different localizations, especially when the 
posterobasal region is involved in the infarct evolution as it was already described in 
several papers [22, 64, 67, 70, 112]. Overall the diagnostic efficacy was more 
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pronounced in cases of differentiating between transmural late enhancement and 
viable areas, but yielded similarly significant AUC values in the detection of 
subendocardial late enhancement for the UV value. We demonstrated good 
diagnostic efficacy for both the UV and BV values in animals with infarction on the 
LAD territory, and the UV value exhibited good efficacy in the Cx coil group also. 
On the other hand the diagnostic efficacy of the BV value disappeared in the Cx coil 
group, as the AUC values did not appeared statistically significant. In this study the 
accuracy of the UV value was more pronounced than the accuracy of the BV value. 
The UV value is influenced by contact stability and far field electrical potentials, the 
BV value depends from the orientation of the tip electrode on the endocardial 
surface, this latter fact may increase the number of false positive points [22, 58]. One 
further explanation for this phenomenon could be the greater variability of BV 
values, reported by Fallavollita et al. [79], however our study was carried in the acute 
setting of MI. Interestingly the relationship between the UV value and the LvmassED 
was significant (as mentioned in Chapter 4.4.2) and the correlation between the UV 
value and the wall thickness values were also significant (Chapter 3.3.3) in the 
segmental analysis, so these data supports the better utility of the UV value in this 
setting and this is could be a consequence of the above mentioned influencing role of 
far field potentials. The diagnostic accuracy of the LLS value highly depends on the 
homogeneity and number of points as it was emphasized in the previous discussion, 
therefore it did not identify correctly the presence or absence of the infarcted area.  
[62, 79, 80]. 
In conclusion, EMM indicated accurately the presence and location of the 
infarcted area both in the reperfused and nonreperfused MI model. The EMM 
derived UV values showed good correlation with the global left ventricular function, 
and regional viability data and indicated properly the presence of subendocardial and 
transmural late enhancement regardless of pathomechanism and localization. ROC 
analysis revealed good diagnostic accuracy for the UV value regarding the different 
localization of MI. The main advantage of EMM is the potential and prompt 
availability in the catheterization laboratory, as a reliable method for myocardial 
viability measurements regardless of the pathomechanism and location of MI. This 
study proves the diagnostic efficacy of EMM in different clinical settings therefore 
could improve the clinical utilization of this method, especially in cases where 
treatment was not initiated within the desired time range e.g. in late comers, since the 
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main scope of studies regarding the utilization of EMM is the unique possibility of 
intramyocardial therapeutic administration of drugs or biological materials on a 
minimal invasive way to improve left ventricular function. 
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6. Novel findings 
 
Our results outline the investigations of myocardial infarcts with different 
pathomechanism (reperfused or nonreperfused) and localization (LAD or Cx) using 
EMM first time to our knowledge. 
 
The detailed type of segmentation, which was applied in the analysis of both cMRI 
and EMM allows accurate interpretation of the results. 
 
The UV voltage value exhibited good correlation with the segmental average signal 
intensity values and the value of infarct transmurality, which also indicates the role 
in the differentiation between viable and nonviable tissue.  
 
The EMM derived UV value was able to detect infarct areas characterized by low 
voltage values in the reperfused and similarly in the nonreperfused MI model. 
 
The UV value could indicate the presence of nonviable tissue, which was 
independent from the localization of MI. 
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7. Appendix 
Summary of the different closed chest techniques for MI induction from the aspect of 
mortality, VF, reperfusion, and infarct size measurements 
Authors Method Nr. of  
animal
s 
Mortality 
rate 
Infarct size 
measuring 
method 
Reperfusion Rate of VF 
Capone et 
al., 1975  
Balloon 
occlusion 
LAD  
15  n.a.  ST segment 
elevation  
No 
reperfusion  
n.a.  
Kren et al., 
2010  
Balloon 
occlusion 
LAD  
4  n.a.  Only qualitative 
histological 
analysis  
After 90 
min. 
occlusion  
n.a.  
Krombach 
et al., 2005  
Balloon 
occlusion 
LAD  
44  22,73%  TTC staining  
Reperfused: 
15,8± 5,1% 
Nonreperfused: 
21,5±8,7%  
After 45 
min. 
occlusion/no 
reperfusion  
59,1%  
Perez de 
Prado et al., 
2009  
Balloon 
occlusion 
LAD  
15  33%  Histology (HE 
and Masson 
trichrome) 
20,4±4,3%  
After 75 
min. 
occlsuion  
87%  
Saeed et al., 
2010  
Balloon 
occlusion 
LAD 
18  22,22%  Three days after 
induction  
MR infarct size: 
15,5±0,7% 
TTC staining: 
15,0±1%  
After 90 
min. 
occlusion  
n.a.  
Suzuki et 
al., 2007  
Balloon 
occlusion 
LAD 
78  20,51%  TTC staining 
7days after 
induction  
60 min proximal 
LAD occl.: 
18,3±1,4% 
30 min proximal 
LAD occl.: 
5,8±6,6% 
60 min mid 
LAD occl.: 
13±1,4%  
After 30 or 
60 min. 
occlusion  
40%  
Dib et al., 
2006  
Coil 
deployment  
LAD  
44  20,45%  Histology: 
14,2±2,9%  
No 
reperfusion  
13,6%  
Peukert et 
al., 2009  
Coil 
deployment  
Cx  
20  25% 
(overall: 
35%)  
Two days after 
induction  
MR infarct size: 
4,4±2,3 cm3 
TTC staining: 
4,3±2,2 cm3  
No 
reperfusion  
45%  
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Uriuda et 
al., 1997  
Coil 
deployment  
LAD  
40  n.a.  Open/closed 
chest lysis with  
rt-PA,  
TTC staining: 
13±8 / 15±5%  
Lysis with 
rt-PA  
15%  
Abegunewar
dene et al., 
2009  
Balloon 
occlusion/ 
thrombin 
injection  
LAD  
27  48,15%  Eight weeks 
after induction  
MR infarct size: 
30 min 
occlusion:  
5,3±5,4% 
45 min. 
occlusion: 
9,7±3,4% 
No reperfusion: 
16,9±2,1%  
After 30 or 
45 min. 
occlusion/no 
reperfusion  
44,44%  
Eldar et al., 
1994  
Injection of 
agarose gel 
microbeads  
LAD  
11  36,36%  Epicardial 
infarct area: 
8,8±5% 
(11-32% of the 
left ventricular 
surface)  
No 
reperfusion  
n.a.  
Naslund et 
al., 1990  
injection of a 
2 mm ball 
into LAD or 
Cx or RCA. 
Reperfusion 
was achieved 
by retraction 
of the ball via 
an attached 
filament  
78  6,5%  TTC staining 
(expressed as 
infarct weight 
as % of 
myocardium at 
risk)  
30 min. 
occlusion: 
6,72±2,51% 
60 min. 
occlusion: 
8,21±2,56% 
90 min. 
occlusion: 
9,25±2,5% 
After 30, 60 
or 90 min. 
occlusion  
15,9%  
Agress et 
al.,  1952  
Coronary 
embolization 
with graded 
microspheres  
49  34,7%  n.a.  No 
reperfusion  
28,57%  
Salazar et 
al., 1961  
Endothelial 
electrical 
injury in the 
LAD or Cx  
23  0%  n.a.  No 
reperfusion  
n.a.  
Reffelmann 
et al.,2003  
Foam sponge 
deployment in 
the Cx (LAD)  
21  38%  n.a.  No 
reperfusion  
76,2% (VT 
and VF)  
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